Literature DB >> 34190718

Rose Bengal Photodynamic Antimicrobial Therapy: A Pilot Safety Study.

Jaime D Martinez1,2,3, Esdras Arrieta2, Andrea Naranjo1,2,4, Pedro Monsalve1,4, Keenan J Mintz5, Jeffrey Peterson2,6, Alejandro Arboleda2, Heather Durkee2,7, Mariela C Aguilar2, Daniel Pelaez7,8, Sander R Dubovy1,4, Darlene Miller1,6, Roger Leblanc5, Guillermo Amescua1,2, Jean-Marie Parel1,2,7.   

Abstract

PURPOSE: To evaluate the in vivo corneal changes after Rose Bengal photodynamic antimicrobial therapy (RB-PDAT) treatment in New Zealand White rabbits.
METHODS: Sixteen rabbits were divided into 5 groups. All groups underwent deepithelialization of an 8 mm diameter area in the central cornea. Group 1: balanced salt solution drops only, group 2: 0.2% RB only, group 3: green light exposure (525 nm, 5.4 J/cm2) only, group 4: 0.1% RB-PDAT, and group 5: 0.1% RB-PDAT. All rabbits were followed clinically. Group 5 rabbits were followed using anterior segment optical coherence tomography (AS-OCT) and clinically. On day 35 after initial treatment, 1 rabbit from group 5 was re-exposed to green light (5.4 J/cm2) to evaluate reactivation of the remaining RB dye, and terminal deoxynucleotyl transferase-mediated UTP-biotin-nick-end labeling assay was performed on corneal cryosections.
RESULTS: Complete reepithelization was observed, and corneas remained clear after treatment in all groups. In group 5, AS-OCT revealed a cross-linking demarcation line. AS-OCT showed RB fluorescence and collagen cross-linking in all treated eyes of group 5 animals after 5 weeks of treatment. Photobleached RB retention in the corneal stroma was corroborated by fluorescence confocal microscopy on frozen sections. There was no evidence of a sustained cytotoxic effect through terminal deoxynucleotyl transferase-mediated UTP-biotin-nick-end labeling at 5 weeks.
CONCLUSIONS: RB-PDAT with 0.1% RB is a safe procedure. There was no difference clinically and on histopathology compared with control groups. In eyes where RB dye is retained in the corneal stroma after 1 month of treatment, oxidative stress is not evidenced at long term.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34190718      PMCID: PMC8504203          DOI: 10.1097/ICO.0000000000002717

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   3.152


  21 in total

1.  Rose bengal photodynamic antimicrobial therapy to inhibit Pseudomonas aeruginosa keratitis isolates.

Authors:  Heather Durkee; Alejandro Arboleda; Mariela C Aguilar; Jaime D Martinez; Karam A Alawa; Nidhi Relhan; Jorge Maestre-Mesa; Guillermo Amescua; Darlene Miller; Jean-Marie Parel
Journal:  Lasers Med Sci       Date:  2019-12-23       Impact factor: 3.161

2.  Vital staining of the cornea and conjunctiva; with a mixture of fluorescein and rose bengal.

Authors:  M S Norn
Journal:  Am J Ophthalmol       Date:  1967-12       Impact factor: 5.258

3.  Rose Bengal- and Riboflavin-Mediated Photodynamic Therapy to Inhibit Methicillin-Resistant Staphylococcus aureus Keratitis Isolates.

Authors:  Francisco Halili; Alejandro Arboleda; Heather Durkee; Mukesh Taneja; Darlene Miller; Karam A Alawa; Mariela C Aguilar; Guillermo Amescua; Harry W Flynn; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2016-03-23       Impact factor: 5.258

4.  Effect of Riboflavin/Rose Bengal-Mediated PACK-CXL on Acanthamoeba Trophozoites and Cysts in Vitro.

Authors:  Hatice Tuba Atalay; Funda Dogruman-Al; Fakhriddin Sarzhanov; Mehmet Cüneyt Özmen; Atike Burçin Tefon; Yavuz Kemal Arıbaş; Kamil Bilgihan
Journal:  Curr Eye Res       Date:  2018-08-07       Impact factor: 2.424

5.  Human Corneal Changes After Rose Bengal Photodynamic Antimicrobial Therapy for Treatment of Fungal Keratitis.

Authors:  Jaime D Martinez; Andrea Naranjo; Guillermo Amescua; Sander R Dubovy; Alejandro Arboleda; Heather Durkee; Mariela C Aguilar; Harry W Flynn; Darlene Miller; Jean-Marie Parel
Journal:  Cornea       Date:  2018-10       Impact factor: 2.651

6.  Assessment of rose bengal versus riboflavin photodynamic therapy for inhibition of fungal keratitis isolates.

Authors:  Alejandro Arboleda; Darlene Miller; Florence Cabot; Mukesh Taneja; Mariela C Aguilar; Karam Alawa; Guillermo Amescua; Sonia H Yoo; Jean-Marie Parel
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

7.  Comparison of fluorescein and rose bengal staining.

Authors:  R P Feenstra; S C Tseng
Journal:  Ophthalmology       Date:  1992-04       Impact factor: 12.079

8.  Rose Bengal Photodynamic Antimicrobial Therapy for Patients With Progressive Infectious Keratitis: A Pilot Clinical Study.

Authors:  Andrea Naranjo; Alejandro Arboleda; Jaime D Martinez; Heather Durkee; Mariela C Aguilar; Nidhi Relhan; Neda Nikpoor; Anat Galor; Sander R Dubovy; Roger Leblanc; Harry W Flynn; Darlene Miller; Jean-Marie Parel; Guillermo Amescua
Journal:  Am J Ophthalmol       Date:  2019-09-05       Impact factor: 5.258

9.  Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.

Authors:  Penny A Asbell; Christine M Sanfilippo; Christopher M Pillar; Heleen H DeCory; Daniel F Sahm; Timothy W Morris
Journal:  JAMA Ophthalmol       Date:  2015-12       Impact factor: 7.389

Review 10.  Anterior Segment Imaging in Ocular Surface Squamous Neoplasia.

Authors:  Sally S Ong; Gargi K Vora; Preeya K Gupta
Journal:  J Ophthalmol       Date:  2016-10-05       Impact factor: 1.909

View more
  1 in total

Review 1.  Fusarium Keratitis-Review of Current Treatment Possibilities.

Authors:  Marek Szaliński; Aleksandra Zgryźniak; Izabela Rubisz; Małgorzata Gajdzis; Radosław Kaczmarek; Joanna Przeździecka-Dołyk
Journal:  J Clin Med       Date:  2021-11-23       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.